Oversight of Laboratory Developed Tests One Year After ACLA v. FDA: Assessing Legislative Proposals in Context

Innovative Insights: Legal Updates in Life Sciences

MIT researchers call for FDA oversight of unregulated AI tools used in US hospitals

Every day, across thousands of American hospitals, artificial intelligence quietly shapes decisions that determine patient outcomes. An algo

FDA Withdraws Proposed Regulation for Asbestos Testing in Cosmetic Talc, Reversing Public Health Progress

In December, 2024, the US Food and Drug Administration (FDA) issued a proposed regulation on testing for the presence of asbestos in cosmeti

EU and US regulators move to phase out animal testing for chemical safety assessments

EU roadmap, released on Monday, envisions full shift to alternative test methods but lacks clear timeline

When Software Stopped Being a Lab Test: How the CY2027 OPPS Rule’s Software as a Medical Service Category, the O1 Status Indicator, and Pulling Lab AI Off the CLFS Reshape Health Tech Investing

Video Preview

Commission accelerates transition away from animal testing in chemical safety assessments

On 1 June, the Commission presented a comprehensive Roadmap towards phasing out animal testing for chemical safety assessments across the EU